Edition:
United Kingdom

Oasmia Pharmaceutical AB (OASM.OQ)

OASM.OQ on NASDAQ Stock Exchange Capital Market

1.37USD
23 May 2018
Change (% chg)

$0.04 (+3.01%)
Prev Close
$1.33
Open
$1.34
Day's High
$1.37
Day's Low
$1.34
Volume
150
Avg. Vol
6,827
52-wk High
$3.10
52-wk Low
$0.80

Latest Key Developments (Source: Significant Developments)

Oasmia Pharmaceutical Says May Offer, Issue, Sell Up to US$25 Mln Shares
Monday, 30 Apr 2018 

April 30 (Reuters) - Oasmia Pharmaceutical AB ::OASMIA PHARMACEUTICAL AB -MAY OFFER, ISSUE, SELL UP TO US$25 MILLION OF SHARES/ADSS, NUMBER OF WARRANTS TO PURCHASE ORDINARY SHARES, COMBINATION OF SECURITIES.  Full Article

Oasmia Pharmaceutical Q2 operating loss shrinks
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Oasmia Pharmaceutical Ab ::OASMIA PHARMACEUTICAL AB Q2 ‍CONSOLIDATED NET SALES AMOUNTED TO TSEK 1,651 COMPARED TO TSEK 56 IN THE SECOND QUARTER THE PREVIOUS YEAR ​.OASMIA PHARMACEUTICAL AB Q2 ‍OPERATING LOSS WAS TSEK 22,129 COMPARED TO TSEK 35,867 IN THE SECOND QUARTER THE PREVIOUS YEAR ​.  Full Article

Oasmia Q4 operating loss widens
Thursday, 8 Jun 2017 

June 8 (Reuters) - Oasmia Pharmaceutical Ab ::Q4 consolidated net sales amounted to 44,000 SEK compared to 59,000 in q4 previous year.Q4 operating loss was 37 mln SEK compared to a loss of 31 mln SEK in q4 previous year.Says the board does not intend to propose any dividends for the financial year May 1, 2016 – April 30, 2017..  Full Article

Oasmia Pharmaceutical Q1 loss per share SEK 0.34
Friday, 2 Sep 2016 

Oasmia Pharmaceutical AB:Q1 loss per share SEK 0.34.  Full Article

Oasmia Pharmaceutical Q1 operating loss narrows
Friday, 2 Sep 2016 

Oasmia Pharmaceutical AB : Q1 consolidated net sales amounted to TSEK 36 compared to TSEK 219 in Q1 previous year .Q1 operating loss was TSEK 32,343 compared to a loss of TSEK 37,819 in Q1 previous year.  Full Article

Oasmia names Fredrik Gynnerstedt as new Chief Financial Officer
Wednesday, 31 Aug 2016 

Oasmia Pharmaceutical AB :Says appoints Fredrik Gynnerstedt as Chief Financial Officer.  Full Article

BRIEF-Oasmia Pharmaceutical Says May Offer, Issue, Sell Up to US$25 Mln Shares

* OASMIA PHARMACEUTICAL AB -MAY OFFER, ISSUE, SELL UP TO US$25 MILLION OF SHARES/ADSS, NUMBER OF WARRANTS TO PURCHASE ORDINARY SHARES, COMBINATION OF SECURITIES Source text (https://bit.ly/2vZYiIp) Further company coverage: